Prostate cancer scare in 2020 turned out to be ‘false alarm' for singer Shaan
'I had a bit of a prostate scare in 2020, which I want to share with you. It almost led to a point where I was told by a few doctors that this could be prostate cancer, but it turned out it was a false alarm,' he told reporters.
Sharing his experience at the launch of MenCan, an initiative of Urologic Oncology Disease Management Group (URO DMG), a unit of the Tata Memorial Centre (TMC) here, he also urged people to get medical tests done, saying health was of utmost importance.
Mumbai, Apr 24 (PTI) Prostate cancer scare five years ago compelled noted playback singer Shaan to go for a check-up, which then confirmed that it was just a 'false alarm'.
'Since then, I've been very, very careful in terms of getting my regular tests done. And that is something that I've done on a personal level, which again, when I share with my friends, it's very ticklish, it's very funny. Therefore, I realised that it's something that we need to, you know, create more awareness,' he said.
The voice behind countless hits such as 'Tanha Dil', 'Musu Musu Hasi', 'Jab Se Tere Naina' and 'Chand Sifarish', is now going to be the brand ambassador for MenCan initiative.
MenCan is a non-profit and non-commercial initiative that will address the challenges of prostate, penile and testicular cancers in men.
Shaan said there are certain taboos, stigmas and fear attached to the word cancer.
'The word itself, people don't want to use it, like it's almost like a scary word,' he said.
According to him, he quickly agreed to become the brand ambassador for MenCan because there is a taboo in the society about openly talking about prostate, testicular or penile cancer.
'You don't want to be forthcoming about it. Get yourself checked, get yourself administered because it feels kind of violated, scary. But we have to get over that because at the end of the day, your health, especially a man's health, is important. If a man is not in his best health, it's going to affect the family,' he said.
'We need to talk about it. We need to bring awareness. And so I'm very happy that though I'm completely a lay person in the medical and scientific world, if I can be of any use, if I've been chosen to do this, I'll do my utmost to support MenCan,' he added. PTI SM NP
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
4 hours ago
- The Print
Renalyx Health Systems to invest Rs 800 cr for setting up 3 dialysis machine production units
Currently, the company manufactures RxT 17 through contract manufacturing and with the launch of RxT 21, it will set up its own facilities at Bengaluru and Mysuru in Karnataka and at Mumbai in Maharashtra, Renalyx Health Systems Founder and Director Shyam Vasudeva Rao told PTI. RENALYX – RxT 21 machine is world's first fully indigenous, AI and cloud-enabled smart hemodialysis machine with real-time remote monitoring and clinical connectivity facility, the company said. Mumbai, Jun 11 (PTI) Bengaluru-headquartered Renalyx Health Systems on Wednesday said it is planning to invest Rs 800 crore in the next four years to set up three manufacturing units to produce RENALYX – RxT 21 machine that will help dialysis affordable and accessible to a larger population. This is expected to raise the manpower of the company to over 500 people in 1-2 years from the current 100, he added. 'RxT 21 makes Renalyx the sixth company globally and first in India to produce an advanced dialysis machine with EU CE certification, a mandatory conformity marking for products sold within the European Economic Area (EEA). We are aiming for an annual capacity of 5,000 machines in the company-owned manufacturing units,' he added. The Indian CDSCO (Central Drugs Standard Control Organisation) approval of the machine is in its final stages and is expected by July this year, while the US FDA approval process is underway and anticipated by March 2026, he said. When asked how the company is planning to raise Rs 800 crore for setting up the manufacturing units, Rao said, the company will get it through a mix of foreign direct investment (FDIs), equity and debt. 'The company plans to raise funds through the sale of equity, backed by strong interest from prominent Indian and international investors. In addition, it will raise debt, and the promoters will also invest capital. We are also planning to go public within the next three years,' he added. Renalyx Health Systems is a technology innovation company which is focused on delivering inclusive solutions for comprehensive renal care. With initial deployments of the machine planned in Maharashtra and Karnataka, the company will go for rapid pan-India distribution of RxT 21 with its partners as well as exports to other countries. Rao said the company has penetrated international markets, and has secured orders from South Africa, the USA, and Europe. In India, Renalyx plans to install RxT 21 at primary health centres (PHC), community health centres (CHC), private dialysis centres and hospitals to make renal care available to a large number of people. PTI SM HVA This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
The Print
6 hours ago
- The Print
Delhi hospitals see spike in cases of heat-related illnesses
At Fortis Escorts Heart Institute, 7-10 per cent of the total outpatient department (OPD) patients have conditions linked to the heatwave, while 5-8 per cent have sought consultations for related symptoms, said Dr Avi Kumar, senior consultant of pulmonology at the hospital. People who work directly under the sun are more affected by the heatwave, for which a red alert has been issued in Delhi. New Delhi, Jun 12 (PTI) Hospitals across the national capital have been seeing a surge in patients due to the intense heatwave of the last few days, doctors said on Thursday. 'The cases that are coming are largely mild and not serious enough to require admission,' the doctor said. At the Delhi government-run LNJP Hospital, authorities have designated a separate area for patients who are working under the sun. 'The patients coming in are rickshaw-pullers, drivers, labourers, mostly those who are engaged in manual work. Patients come in with complaints of abdominal pain, vomitting, dehydration, dizziness. These cases have increases in the last three days,' the official added. Concurring with the LNJP official, Dr Mukesh Mehra, senior director of internal medicine at Max Super Speciality Hospital, said patients of heatwave mainly experience symptoms like include dizziness, dry flushed skin, disorientation, and gastrointestinal discomfort. He stressed that recognising the symptoms and implementing preventive measures is very important. Doctors warned that elderly individuals, children, and those with chronic conditions are particularly at risk and should take extra precautions. A red alert, the most severe warning level, was issued for Delhi as the city experiences an extreme heatwave, with temperatures rising between 40.9 and 45.0 degrees Celsius this week. 'Precautionary measures such as staying hydrated, avoiding outdoor activities during peak hours, wearing light and loose clothing, eating light meals, and remaining in cool environments, must be followed,' Kumar added. PTI SGV SLB SLB SKY SKY This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Time of India
9 hours ago
- Time of India
Renalyx Health Systems to invest Rs 800 cr for setting up 3 dialysis machine production units
Mumbai: Bengaluru-headquartered Renalyx Health Systems on Wednesday said it is planning to invest Rs 800 crore in the next four years to set up three manufacturing units to produce RENALYX - RxT 21 machine that will help dialysis affordable and accessible to a larger population. RENALYX - RxT 21 machine is world's first fully indigenous, AI and cloud-enabled smart hemodialysis machine with real-time remote monitoring and clinical connectivity facility, the company said. Currently, the company manufactures RxT 17 through contract manufacturing and with the launch of RxT 21, it will set up its own facilities at Bengaluru and Mysuru in Karnataka and at Mumbai in Maharashtra, Renalyx Health Systems Founder and Director Shyam Vasudeva Rao told PTI. This is expected to raise the manpower of the company to over 500 people in 1-2 years from the current 100, he added. "RxT 21 makes Renalyx the sixth company globally and first in India to produce an advanced dialysis machine with EU CE certification, a mandatory conformity marking for products sold within the European Economic Area (EEA). We are aiming for an annual capacity of 5,000 machines in the company-owned manufacturing units," he added. The Indian CDSCO (Central Drugs Standard Control Organisation) approval of the machine is in its final stages and is expected by July this year, while the US FDA approval process is underway and anticipated by March 2026, he said. When asked how the company is planning to raise Rs 800 crore for setting up the manufacturing units, Rao said, the company will get it through a mix of foreign direct investment (FDIs), equity and debt. "The company plans to raise funds through the sale of equity, backed by strong interest from prominent Indian and international investors. In addition, it will raise debt, and the promoters will also invest capital. We are also planning to go public within the next three years," he added. Renalyx Health Systems is a technology innovation company which is focused on delivering inclusive solutions for comprehensive renal care. With initial deployments of the machine planned in Maharashtra and Karnataka, the company will go for rapid pan-India distribution of RxT 21 with its partners as well as exports to other countries. Rao said the company has penetrated international markets, and has secured orders from South Africa, the USA, and Europe. In India, Renalyx plans to install RxT 21 at primary health centres (PHC), community health centres (CHC), private dialysis centres and hospitals to make renal care available to a large number of people. PTI
